Skip to main content
Diagnamed Holdings Corp. logo

Diagnamed Holdings Corp. — Investor Relations & Filings

Ticker · DMED ISIN · CA25245D1033 LEI · 529900UL67VSZMMIHW28 CSE Mining and quarrying
Filings indexed 162 across all filing types
Latest filing 2024-03-01 Regulatory Filings
Country CA Canada
Listing CSE DMED

About Diagnamed Holdings Corp.

https://diagnamed.com/

Diagnamed Holdings Corp. is a clean-technology company focused on the discovery and production of naturally occurring geologic, or "white," hydrogen. The company employs advanced subsurface analytics and proprietary soil-gas survey methods to locate hydrogen accumulations in favorable geological settings. Its core strategy involves utilizing clean, non-electrolytic extraction technologies, including patented electromagnetic stimulation tools, to release hydrogen from iron-rich rock formations and depleted reservoirs, minimizing environmental impact and achieving low-cost production. Diagnamed is actively developing Canada's Natural Hydrogen Corridor, with exploration programs concentrated in the Timiskaming District of Ontario and Québec, aiming to supply sustainable fuel to industrial, municipal, and transportation sectors.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2024-03-01 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-03-01 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the test launch of a new brain health AI solution called CERVAI™ by DiagnaMed Holdings Corp. It contains no financial data, no regulatory filings, no voting results, no management or board changes, no earnings or interim reports, and no audit or legal information. It is a corporate announcement about a product launch and pilot program, typical of a general regulatory announcement or news release. The document length is 8007 characters, which is not a report but an announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2024-02-28 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2024-01-30 English
Annual MD&A - English.pdf
Regulatory Filings
2024-01-30 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2024-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.